Companies

AbbVie

Humira's patent thicket, 27 price increases, nurse "ambassadors" and product hopping

Aduhelm, a congressional investigation and a $900 million kickback settlement

Insulin prices, a Medicaid fraud verdict, Zyprexa and the GLP-1 wars

Acthar Gel's price, Medicaid rebate fraud, an FTC monopoly case and two bankruptcies

Zolgensma's data scandal, sham speaker programmes, foreign bribery and generic price-fixing

Insulin, Ozempic and Wegovy pricing, a Victoza settlement and a US–EU safety gap

From a record criminal fine to the fight over its ATTR-CM franchise

Two guilty pleas, the opioid crisis and a $7.4 billion exit

Contested approvals, patient deaths and a standoff with the FDA

Generic price-fixing, Copaxone kickbacks and opioid liability